Killian Meara

Exposure to a segment of the viral spike protein induced COVID-19 like symptoms and caused lung damage similar to those with the disease.

Thailand steps up travel restrictions among a rapidly spreading third wave of the disease.

The Advisory Committee on Immunization Practices voted 10-4 with 1 abstention to resume the rollout and administration of the Janssen shot.

While the addition of outside air into a building showed a clear benefit, too much air exchange can have a negative impact.

The Johnson & Johnson shot showed an efficacy of 66.9% and 66.1% on the 2 primary endpoints, with a higher efficacy against severe-critical disease.

While no evidence of any viral RNA was detected in patients brain cells, investigators found a significant amount of neurological damage.

High levels of anxiety among immunocompromised children and their guardians highlights the need to clearly define COVID-19 risk.

Federal regulators authored a 12 page report citing several examples of misconduct within the plant, including improperly trained employees.

Simple daily measures could help to lower the risk of severe disease and transmission, including using mouthwash.

A marker that triggers T cells to fight an infection in the gut was found in small numbers in those with a SARS-CoV-2 infection.

The SAA biomarker could allow physicians the opportunity to better care for and manage a patient’s course of disease.

The committee stressed that the events are exceedingly rare, and that the vaccine's benefits outweigh the potential risks.

Vaccine rollout in Germany intensifies as more doses are delivered to the country.

Results from the study data reinforce the need to adhere to public health measures by people who have been vaccinated.

While RT-PCR testing is difficult for confirming a reinfection with the virus, whole genome sequencing may be a more reliable measure.

The ongoing pandemic has caused a severe decrease in childhood vaccinations, while some rates have recovered, others have not and clinicians are urging caregivers to have their children receive their shots.

The 2 shot mRNA vaccine has a high efficacy against COVID-19, but long term data for its protection is not there yet, and emerging variants may present a challenge.

More than half of urine cultures were found to be contaminated and 1 in 5 of the patients were prescribed an antibiotic.

The two measures were shown to prevent viral outbreaks if at least 60% of a population followed them.

The monoclonal antibody cocktail reduced symptomatic infections by 72% in the first week and 93% in following weeks.

Despite a growing number of cases, millions gather in India for Hindu festival.

Even with just a mild case of COVID-19, many of the participants reported long-term symptoms that had a negative impact on their life.

While patients who developed a severe case of COVID-19 were at the highest risk, it was not limited to them.

Face masks protect from COVID-19, but multilayered ones made of certain materials perform better than others.

While the therapy did not meet its primary endpoint, it did show a statistically significant reduction in mortality compared to stand of care alone.

While symptom checkers have the potential to significantly help with overburdened systems, not enough people know about them.

The preclinical study showed that intranasal administration of OMV-Spike protected against the SARS-CoV-2 virus.

The therapy used plasma from recoverees with high levels of antibodies and proved to significantly improve clinical outcomes.

mRNA-1273 was seen to elicit antibodies for COVID-19 180 days following full dosage in a phase 1 trial and is still recommended for use by the authors.

The study suggests that proper air ventilation and masks could reduce the risk of infections in classrooms by up to 50%, making a 6-foot social distancing requirement unnecessary.